Utrecht, Netherlands

Farid Abedin Dorkoosh



Average Co-Inventor Count = 2.9

ph-index = 2

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2011-2013

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Farid Abedin Dorkoosh: Innovator in Pharmaceutical Development

Introduction

Farid Abedin Dorkoosh is a notable inventor based in Utrecht, Netherlands. He has made significant contributions to the field of pharmaceuticals, holding a total of 3 patents. His work focuses on improving the formulation and delivery of medications, which is crucial for patient care and treatment efficacy.

Latest Patents

Among his latest patents, Dorkoosh has developed pharmaceutical tablets of crystalline type II aripiprazole. This formulation is designed to have a reduced dissolution profile variability upon storage, enhancing the stability and reliability of the medication. Additionally, he has created zolpidem tablets featuring a modified release mechanism, designed as a tablet-in-tablet dosage form. This innovative approach aims to improve the therapeutic outcomes for patients requiring zolpidem.

Career Highlights

Dorkoosh is currently employed at Synthon B.V., a company known for its focus on developing complex generics and specialty pharmaceuticals. His role at Synthon allows him to leverage his expertise in pharmaceutical sciences to contribute to the development of advanced drug formulations.

Collaborations

Throughout his career, Dorkoosh has collaborated with several talented professionals, including Korinde Annemarie Jansen and Gerrit J B Ettema. These collaborations have fostered a creative environment that encourages innovation and the sharing of ideas.

Conclusion

Farid Abedin Dorkoosh is a distinguished inventor whose work in pharmaceutical development has led to significant advancements in medication formulation. His contributions are vital to improving patient outcomes and enhancing the effectiveness of treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…